<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="379149" id="root" date="1997-02-14" xml:lang="en">
<title>USA: European Union passes Immunomedics product.</title>
<headline>European Union passes Immunomedics product.</headline>
<dateline>MORRIS PLAINS, N.J. 1997-02-14</dateline>
<text>
<p>The European Union has given Immunomedics Inc final approval to market and sell an antibody fragment called LeukoScan, which helps locate sites of infection within the body, the company said Friday.  </p>
<p>Immunomedics, a biopharmaceutical company, said it had begun negotiations to find a partner to distribute its product in the union.</p>
<p>&quot;The approved indication for LeukoScan is the detection and diagnosis of osteomyelitis (bone infection) involving long bones, particularly in diabetic patients with foot ulcers, for which osteomyelitis can be a frequent complication,&quot; it said. The company also said the U.S. Food and Drug Administration had accepted for filing its Biologics License Application for LeukoScan. It said the administration was reviewing the application for the same indications as in Europe, plus an additional indication for use in patients with acute, atypical appendicitis.</p>
<p>LeukoScan is a small antibody fragment that seeks out and binds to granulocytes (white blood cells) that accumulate around infections and inflammations.  The fragment reveals the sites because it is easily identifiable.</p>
<p>((-- New York Newsdesk 212 859-1610))</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="EEC">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C13">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
  <code code="C22">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
  <code code="G15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
  <code code="G152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
  <code code="GCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-14"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-02-14"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-02-14"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="MORRIS PLAINS, N.J."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
